Literature DB >> 16536920

Unusual gamma heavy chain disease protein in a patient with splenic marginal-zone lymphoma.

Keiko Morita1, Hiromi Kawamoto, Honami Takada, Shinobu Nakamura, Kazuyoshi Ishii, Yasuyuki Okamoto.   

Abstract

We conducted an electrophoretic analysis of monoclonal gamma-globulin found in the serum of a patient with splenic marginal-zone lymphoma. This monoclonal protein showed electrophoretic mobility to the gamma region and reacted with anti-immunoglobulin (IgG) antiserum but not with anti-kappa or anti-lambda light chain antisera. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting of the monoclonal protein-rich gamma-globulin fraction extracted from the sliced gel revealed the presence of two types of abnormal IgG molecule, low- and high-molecular-weight IgG, neither of which reacted with anti-kappa or anti-lambda light chain antisera. Additionally, an abnormal high-molecular-weight gamma heavy chain was identified by reducing SDS-PAGE. These findings suggest that this monoclonal protein is composed only of gamma heavy chains of normal and larger size. The presence of abnormal serum immunoglobulin composed of only gamma heavy chain has been known as a fundamental feature of gamma heavy chain disease (HCD). However, the unique composition of monoclonal gamma-globulin makes our case distinct from typical gammaHCD, which is characterized by an abnormal truncated low-molecular-weight gamma heavy chain. Thus, the unusual monoclonal protein may have been produced by a somatic mutation of IgH gene associated with splenic marginal-zone lymphoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16536920     DOI: 10.1258/000456306776021490

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  4 in total

1.  Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases.

Authors:  Shannon Bieliauskas; Raymond R Tubbs; Chris M Bacon; Camellia Eshoa; Kathryn Foucar; Sarah E Gibson; Steven H Kroft; Aliyah R Sohani; Steven H Swerdlow; James R Cook
Journal:  Am J Surg Pathol       Date:  2012-04       Impact factor: 6.394

2.  Identification of gamma heavy chain disease using MALDI-TOF mass spectrometry.

Authors:  Katie L Thoren; Marion Eveillard; Patrick Chan; Sital Doddi; Sun Cho; Kazunori Murata
Journal:  Clin Biochem       Date:  2019-12-26       Impact factor: 3.281

3.  Gamma heavy chain disease in a patient with rheumatoid arthritis--a laboratory evaluation.

Authors:  Wibke Johannis; Jenny Blommer; Andreas R Klatt; Joerg H Renno; Klaus Wielckens
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

4.  Gamma heavy-chain disease accompanied with follicular lymphoma: a case report.

Authors:  Paula San-José; Vicente Aguadero; Granada Perea; Meritxell Estrada; Eugenio Berlanga
Journal:  Biochem Med (Zagreb)       Date:  2018-02-15       Impact factor: 2.313

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.